ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
HRT tablets linked to higher blood clot risk: study
January 11, 2019Certain types of hormone replacement therapy (HRT) could lead to increased risk of venous thromboembolism (VTE), a new study has suggested. -
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy
December 17, 2018Among patients with cancer starting chemotherapy who are at intermediate-to-high risk, rates of venous thromboembolism are significantly lower for thromboprophylaxis with apixaban versus placebo..... -
Janssen Submits sNDA for Xarelto to Prevent VTE in Acute Medically Ill Patients
December 17, 2018Janssen Pharmaceutical announced the submission of a supplemental New Drug Application (sNDA) for Xarelto (rivaroxaban) to the U.S. Food and Drug Administration (FDA) for the prevention of...... -
EU OKs low-dose Xarelto to prevent recurrent VTE
November 03, 2017A lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients.
Pharma Sources Insight January 2025
